Ishida T, Lewis R M, Hartley C J, Entman M L, Field J B
Endocrinology. 1983 Mar;112(3):1098-109. doi: 10.1210/endo-112-3-1098.
Previous studies in anesthetized dogs demonstrated that basal hepatic extraction of insulin and glucagon are approximately 50 and 10-20%, respectively. Because of the stress of anesthesia and surgery, these values may not be relevant to normal physiology. In this study, hepatic extraction of insulin and glucagon were compared in conscious and anesthetized dogs. The conscious dogs had chronically implanted catheters in the portal and hepatic vein and the carotid artery and Doppler flow probes on the portal vein and hepatic artery. The mean basal portal vein insulin (42 +/- 10 and 44 +/- 7 microU/ml, respectively) and glucagon (247 +/- 37 and 219 +/- 20 pg/ml, respectively) concentrations were similar in conscious and anesthetized animals. The mean basal portal vein, but not hepatic artery, plasma flow was significantly increased in conscious dogs (462 +/- 62 vs. 294 +/- 35 ml/min, respectively). Despite the increased portal vein plasma flow in conscious animals, the basal hepatic extractions of insulin (42 +/- 6 vs. 39 +/- 6%, respectively) and glucagon (12 +/- 7 vs. 7 +/- 7%, respectively) were similar in both types of animals. Arginine and cholecystokinin-pancreozymin (CCK-PZ) infusion, which increased the amount of insulin and glucagon presented to the liver in conscious and anesthetized dogs, significantly decreased the hepatic extraction of insulin. Hepatic extraction of glucagon did not change in either group of animals. In contrast, infusion of insulin (1.0 mU/kg X min) and glucagon (4 ng/kg X min) into the portal system did not alter hepatic extraction of insulin even though the amounts of insulin and glucagon presented to that organ were similar to those obtained with arginine and CCK-PZ. The basal arterial glucose level was significantly lower in the conscious dogs but the basal hepatic glucose output was similar in the two groups. The glucose response to the infusion of arginine and CCK-PZ and exogenous hormones was significantly greater in the anesthetized animals.
以往对麻醉犬的研究表明,胰岛素和胰高血糖素的基础肝脏摄取率分别约为50%和10%-20%。由于麻醉和手术的应激,这些数值可能与正常生理情况无关。在本研究中,对清醒犬和麻醉犬的胰岛素和胰高血糖素肝脏摄取情况进行了比较。清醒犬长期在门静脉、肝静脉、颈动脉植入导管,并在门静脉和肝动脉上安装多普勒血流探头。清醒动物和麻醉动物的基础门静脉胰岛素平均浓度(分别为42±10和44±7微单位/毫升)和胰高血糖素平均浓度(分别为247±37和219±20皮克/毫升)相似。清醒犬的基础门静脉血浆流量显著增加(分别为462±62和294±35毫升/分钟),但肝动脉血浆流量未增加。尽管清醒动物的门静脉血浆流量增加,但两种动物的胰岛素基础肝脏摄取率(分别为42±6%和39±6%)和胰高血糖素基础肝脏摄取率(分别为12±7%和7±7%)相似。在清醒和麻醉犬中,输注精氨酸和胆囊收缩素-促胰酶素(CCK-PZ)可增加肝脏所接触的胰岛素和胰高血糖素量,显著降低胰岛素的肝脏摄取率。两组动物中胰高血糖素的肝脏摄取率均未改变。相比之下,向门静脉系统输注胰岛素(1.0微单位/千克·分钟)和胰高血糖素(4纳克/千克·分钟),即使该器官所接触的胰岛素和胰高血糖素量与输注精氨酸和CCK-PZ时相似,也不会改变胰岛素的肝脏摄取率。清醒犬的基础动脉血糖水平显著较低,但两组的基础肝脏葡萄糖输出相似。麻醉动物对输注精氨酸、CCK-PZ和外源激素的葡萄糖反应显著更大。